The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 12, 2025
Filed:
May. 20, 2019
Applicant:
Anavex Life Sciences Corp., New York, NY (US);
Inventors:
Christopher U. Missling, New York, NY (US);
Mohammad Michel Afshar, Paris, FR;
Frédéric Parmentier, Fresnes, FR;
Assignee:
ANAVEX LIFE SCIENCES CORP., New York, NY (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6883 (2018.01); A61K 31/13 (2006.01); A61K 31/135 (2006.01); A61K 31/15 (2006.01); A61K 31/27 (2006.01); A61K 31/341 (2006.01); A61K 31/4045 (2006.01); A61K 31/438 (2006.01); A61K 31/439 (2006.01); A61K 31/445 (2006.01); A61K 31/485 (2006.01); A61K 31/495 (2006.01); A61K 31/5375 (2006.01); A61K 31/55 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
A61K 31/341 (2013.01); A61K 31/13 (2013.01); A61K 31/135 (2013.01); A61K 31/15 (2013.01); A61K 31/27 (2013.01); A61K 31/4045 (2013.01); A61K 31/438 (2013.01); A61K 31/439 (2013.01); A61K 31/445 (2013.01); A61K 31/485 (2013.01); A61K 31/495 (2013.01); A61K 31/5375 (2013.01); A61K 31/55 (2013.01); A61P 25/28 (2018.01); C12Q 1/6883 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract
The present disclosure provides genetic polymorphisms associated with an altered response of a subject to Sigma-1 receptor therapy. Also described is use of the polymorphisms to personalize treatment for subjects in need of Sigma-1 receptor therapy such as treatment of neurodevelopmental and neurodegenerative diseases and conditions.
Missling, Christopher. (2025). Optimized sigma-1 agonist method of responder selection and treatment (U.S. Patent No. 12383526). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12383526
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile